SOLICITATION NOTICE
68 -- Luminex xMAP Salmonella Serotyping Assay (xMAP SSA) and xMAP O-Antigen Expansion Reagent Kits
- Notice Date
- 8/17/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325998
— All Other Miscellaneous Chemical Product and Preparation Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Philadelphia, 200 Chestnut Street, Room 900, Philadelphia, Pennsylvania, 19106, United States
- ZIP Code
- 19106
- Solicitation Number
- FDA-1151872
- Archive Date
- 9/10/2015
- Point of Contact
- Janice Heard, Phone: 215-717-3093
- E-Mail Address
-
janice.heard@fda.hhs.gov
(janice.heard@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Notice of Intent to Award a Sole Source Contract - FDA-1151872 Description(s): Luminex xMAP Salmonella Serotyping Assay (xMAP SSA) and xMAP O-Antigen Expansion Reagent Kits The Food and Drug Administration, intends to make a sole source award to Luminex for Luminex xMAP Salmonella Serotyping Assay (xMAP SSA) and xMAP O-Antigen Expansion Reagent Kits. The reagents will be used as a rapid serotyping tool to identify the Salmonella isolates obtained from the contaminated foods. Luminex® xMAP® technology enables scientists to measure multiple proteins in a single well. This technology combines advanced fluidics, optics, and digital signal processing with proprietary microsphere technology to deliver multiplexed assay capabilities. Featuring a flexible open-architecture design, xMAP® technology can be configured to perform a wide variety of bioassays quickly, cost-effectively and accurately. The xMAP Salmonella Serotyping Assay and xMAP 0-Antigen Expansion Assay were developed by the CDC for fast, accurate and comprehensive molecular serotyping of Salmonella isolates. These assays consists of four separate tests that detect multiple 0 and H antigens simultaneously, including the ability to identify some serotype-specific antigens for problematic serotypes such as S. Entertidis, S. Typhi and the detection of monophasic variants. The xMAP Salmonella Serotyping Assay and xMAP 0-Antigen Expansion Assay are built on proven Luminex technolog : MicroPlex® Microspheres and Luminex® 100/200 TM. The Luminex Corporation is the sole licensee and manufacturer of the CDC developed xMAP Salmonella Serotyping Assay and xMAP 0-Antigen Expansion Assay catalog. The NAICS Code for this action is 325998. This procurement is made under the authority of 10 USC 2304(c) (1) - only one responsible source. This is a notice of intent to issue this solicitation on a sole source basis. This notice of intent is not a solicitation for competitive proposals. Any other firms desiring consideration must fully identify their interest and capability to provide this item, or submit a proposal within 15 days to the individual listed. A determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. The projected award date is on or about August 28, 2015.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/6e32fb5889f73e8da8aba46a2ecc49ee)
- Place of Performance
- Address: Food & Drug Administration, 5100 Paint Branch Parkway, College Park, Maryland, 20740, United States
- Zip Code: 20740
- Zip Code: 20740
- Record
- SN03842127-W 20150819/150817235446-6e32fb5889f73e8da8aba46a2ecc49ee (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |